Research news

Clinical trial of new dyskinesia drug starts in Sweden

Date

Working together to put patients at the heart of Parkinson's research

Date

Launch of a new toolkit for researchers

Date

Vision tests predict cognitive decline linked to Parkinson's

Date

Scientists in the UK have uncovered evidence that simple vision tests can predict who will develop Parkinson's dementia. And the evidence shows that a loss of wiring in the brain may be the cause. 

New guidance for lab-based researchers on patient and public involvement

Date

We’ve partnered with Alzheimer’s Society and University College London Hospitals (UCLH) Biomedical Research Centre. Together, we’ve developed a new resource to help lab-based researchers with patient and public involvement (PPI).

Levodopa-making tomatoes could provide an affordable medication for Parkinson's symptoms

Date

Scientists in the UK have developed a tomato plant that produces high levels of levodopa. This research may help more people access this important Parkinson's medication.

New trial to drive forward promising treatment for dyskinesia

Date

Parkinson’s UK is joining forces with US charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5m clinical trial of an exciting new drug to combat dyskinesia in people with Parkinson’s.
Husband and wife look out the window

Could an anti-sickness drug treat hallucinations in Parkinson's?

Date

We're funding a new research study into a possible treatment for hallucinations in Parkinson's.

Research finds air pollution may speed up Parkinson's

Date

Researchers in the US have uncovered a link between long-term exposure to pollution and deterioration in health conditions. This includes Parkinson's and Alzheimer's.

Driving research forward during the coronavirus pandemic

Date

A survey of people with Parkinson’s, their carers and loved ones has shown that the majority are still comfortable taking part in research. 548 responses have shaped guidance aimed at researchers. It will help them adapt their studies to ensure the safety and comfort of people with Parkinson's during the coronavirus (COVID-19) pandemic.

Oxford researchers find molecule that may slow or stop the progress of Parkinson's

Date

Parkinson's UK funded research suggests it may be possible to prevent the formation of protein clumps that cause problems in Parkinson's by using microscopic tweezers that pull apart the proteins. This could pave the way for a therapy that could slow or stop the progression of the condition.

$161M worth of Parkinson’s research funding awarded across the globe

Date

The Aligning Sciences Across Parkinson’s (ASAP) initiative has announced the 21 teams to receive grant funding. The ambitious programme aims to accelerate the pace of discovery towards a cure for Parkinson’s.

Trial results show statin drug does not slow Parkinson's

Date

Simvastatin is a drug already used to lower cholesterol, and prevent heart attacks and strokes. Initial results from a major clinical trial show it doesn't have potential to slow the progression of Parkinson's as previously hoped.